Piper Sandler is lowering its growth targets on Boston Beer after a recently disappointing launch of Hard Mountain Dew.
A norovirus vaccine could be on the horizon as cases rise
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.